Treatment of acute host-versus-graft reaction in patients after allogeneic hematopoietic cell transplantation with multipotent mesenchymal stromal cells from a bone marrow donor
- Authors: Petinati NA1, Kuz'mina LA1, Parovichnikova EN1, Liubimova LS1, Gribanova EO1, Shipunova IN1, Drize NI1, Savchenko VG1
-
Affiliations:
- ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
- Issue: Vol 84, No 7 (2012)
- Pages: 26-30
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31049
- ID: 31049
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N A Petinati
ФГБУ "Гематологический научный центр" Минздравсоцразвития России, Москва
Email: loel@mail.ru
L A Kuz'mina
Email: kuzlara@rambler.ru
E N Parovichnikova
Email: elenap@blood.ru
L S Liubimova
Email: lubimova@blood.ru
E O Gribanova
Email: gribanova@blood.ru
I N Shipunova
Email: iranifontova@yandex.ru
N I Drize
Email: ndrize@yandex.ru
V G Savchenko
Email: svg@blood.ru
References
- Mohty M., Apperley J.F. Long-term physiological side effects after allogeneic bone marrow transplantation. Hematology Am Soc Hematol Educ Program 2010; 2010: 229-236.
- Majumdar M.K., Keane-Moore M. et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003; 10: 228-241.
- Svinareva D.A., Shipunova I.N., Ol'shanskaia I. et al. The basic properties of mesenchymal stromal cells from the donor bone marrow: superficial markers. Ter Arkh 2010; 82: 52-56.
- Jones B.J., McTaggart S.J. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 2008; 36: 733-741.
- Djouad F., Charbonnier L.M., Bouffi C. et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007; 25: 2025-2032.
- Jiang X.X., Zhang Y., Liu B. et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-4126.
- Ramasamy R., Fazekasova H., Lam E.W. et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007; 83: 71-76.
- Zhang W., Ge W., Li C. et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 2004; 13: 263-271.
- Krampera M., Glennie S., Dyson J. et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.
- Le Blanc K., Rasmusson I., Gotherstrom C. et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004; 60: 307-315.
- Glennie S., Soeiro I., Dyson P.J. et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821-2827.
- Plumas J., Chaperot L., Richard M.J. et al. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 2005; 19: 1597-1604.
- Corcione A., Benvenuto F., Ferretti E. et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372.
- Deng W., Han Q., Liao L. et al. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 2005; 24: 458-463.
- Le Blanc K., Rasmusson I., Sundberg B. et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
- Muller I., Kordowich S., Holzwarth C. et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells Mol Dis 2008; 40: 25-32.
- Fang D., Seo B.M., Liu Y. et al. Transplantation of mesenchymal stem cells is an optimal approach for plastic surgery. Stem Cells 2007; 25: 1021-1028.
- Ringden O., Uzunel M., Rasmusson I. et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 1390-1397.
- Lazarus H.M., Koc O.N., Devine S.M. et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-398.
- Ringden O., Uzunel M., Rasmusson I. et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 1390-1397.
- Jones B.J., McTaggart S.J. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 2008; 36: 733-741.